Related Experiment Video
Updated: Apr 26, 2026
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
[Role of bowel management program in pediatric patients with fecal incontinence]
Yong Wang1, Jiakang Yu, Jun Zhong
1Department of Pediatric Surgery, Women and Children's Medical Center of Guangzhou, Guangzhou 510623, China. jiakangyu2006@126.com.
Insights
This study shows a new bowel management program effectively treats pediatric fecal incontinence. Consistent enema use and hygiene are key to successful outcomes for children with this condition.
Area of Science:
- Pediatric Gastroenterology
- Colorectal Surgery
Background:
- Fecal incontinence in children poses significant challenges.
- Effective management strategies are crucial for improving quality of life.
Purpose of the Study:
- To evaluate a novel bowel management program for pediatric fecal incontinence.
- To assess the clinical efficacy of this intervention.
Main Methods:
- Retrospective analysis of 19 children with fecal incontinence.
- Data collected between January 2012 and January 2013.
- Evaluation of clinical outcomes following the bowel management program.
Main Results:
- 15 children had genuine fecal incontinence requiring enema treatment.
- 4 children had false fecal incontinence.
- Improvements in soiling and constipation observed in genuine cases; 2 false cases achieved independent defecation, and 2 were cured.
Conclusions:
- The bowel management program is an effective treatment for pediatric fecal incontinence.
- Sustained perianal hygiene through adjusted enema protocols is essential for success.
Objective:
To investigate a new bowel management program for children patients with fecal incontinence.
Methods:
Clinical data of 19 children with fecal incontinence undergoing bowel management program in our center between January 2012 and January 2013 were retrospectively analyzed. The main outcome measure was clinical efficacy of this program.
Results:
Fifteen out of 19 cases were genuine fecal incontinence and required continuous treatment by enema. The other 4 cases were false fecal incontinence. After treatment with this program, stool dirty and constipation were improved in genuine incontinence. Two cases of false continence could control defecation independently by oral administration of antispasmodic drug. Two cases of false continence were cured and did not need medical interference.
Conclusions:
Bowel management program is an effective treatment for pediatric patients with fecal incontinence. The key of success is maintenance of perianal hygiene for 24 hours by continual adjustment of the elements and volumes of enemas.
More Related Videos
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...